Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
New portrait of the oldest-known supernova | Space photo of the day for March 27, 2026 - 2After harsh winter, Ukrainians find joy in releasing bats rescued from war
- 3Blue Origin launches New Glenn rocket on company's first NASA-scale science mission
- 4Manhunt for Brown University shooter continues: FBI releases photos of suspect, announces $50K reward
- 5More parents refusing vitamin K shots for newborns, study finds
- True to life Authenticity d: A Survey of \Certifiable Stories\ Narrative
- African Forests Have Become a Source of Carbon Emissions
- Like many holiday traditions, lighting candles and fireplaces is best done in moderation
- Clones of Stumpy, Washington D.C.'s beloved cherry blossom tree, have flowered for the first time
- Hundreds of Gazans evacuated from Strip for medical treatment - COGAT
- Etymological Experiences on the Wireless transmissions: A Survey of \Learning in a hurry\ Language Web recording
- Nearly half of reindeer have been wiped out and armadillos are in Iowa. Here’s how animals are weathering warming holidays
- Germany's Pistorius: NATO protects Europe from Iranian missiles
- 'Crammed into a cell with vermin at New Year'
